Risk/benefit assessment of tamoxifen to prevent breast cancer - Still a work in progress?

Journal of the National Cancer Institute

Volumn 91, Issue 21, 1999, Pages 1792-1793

  Taylor, A L ^a   Adams Campbell, L L ^a   Wright J T , Jr ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PLACEBO; RALOXIFENE; TAMOXIFEN;

BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; EDITORIAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; LUNG EMBOLISM; MINORITY GROUP; NEGRO; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE;

EID: 0033520785     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.21.1792     Document Type: Editorial

References (8)